Business Description
CS Diagnostics Corp
NAICS : 339112
SIC : 5047
ISIN : US33852L2025
Description
CS Diagnostics Corp is a United States based Corporation, its focus is on improving therapy results and reducing side effects. In addition, it offers international companies in the medical industry access to markets and the service of approval of medical products in Europe and the MENA regions. Furthermore, it develops its own products with the aim of maximizing patient benefit.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 1 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 699.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.08 | |||||
9-Day RSI | 71.19 | |||||
14-Day RSI | 60.74 | |||||
3-1 Month Momentum % | -73.71 | |||||
6-1 Month Momentum % | -86.25 | |||||
12-1 Month Momentum % | -62.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.73 | |||||
Quick Ratio | 5.73 | |||||
Cash Ratio | 5.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -55.71 | |||||
Net Margin % | -55.71 | |||||
EBITDA Margin % | -55.71 | |||||
FCF Margin % | -8.57 | |||||
OCF Margin % | -8.57 | |||||
ROE % | 0.01 | |||||
ROA % | 0.01 | |||||
ROIC % | 0.01 | |||||
3-Year ROIIC % | 7600 | |||||
ROCE % | 0.01 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PB Ratio | 0.04 | |||||
EV-to-EBIT | 446.56 | |||||
EV-to-EBITDA | 446.56 | |||||
EV-to-Revenue | -248.8 | |||||
EV-to-FCF | 2902.67 | |||||
Price-to-Projected-FCF | 0.04 | |||||
Earnings Yield (Greenblatt) % | 0.22 | |||||
FCF Yield % | 0.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CSDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CS Diagnostics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | -0.07 | ||
| EPS (TTM) ($) | - | ||
| Beta | 11.483 | ||
| 3-Year Sharpe Ratio | 0.65 | ||
| 3-Year Sortino Ratio | 1.97 | ||
| Volatility % | 205 | ||
| 14-Day RSI | 60.74 | ||
| 14-Day ATR ($) | 0.017888 | ||
| 20-Day SMA ($) | 0.05893 | ||
| 12-1 Month Momentum % | -62.29 | ||
| 52-Week Range ($) | 0.0105 - 0.4 | ||
| Shares Outstanding (Mil) | 249.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CS Diagnostics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CS Diagnostics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 104 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 13 days | ||
| First quarter earnings results for 2026 | 2026-07-17 | 0.05 (-65.08%) | ||
| General meeting for 2025 | 2026-07-10 | 0.05 (+0.00%) | ||
| Annual report for 2025 | 2026-04-15 | 0.15 (+22.91%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 0.40 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 0.11 (-8.33%) | ||
| Small Cap Growth Virtual Investor Conference | 2025-06-26 12:30 | 0.05 (-10.37%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 0.08 (+14.43%) | ||
| Annual report for 2024 | 2025-04-14 | 0.15 (+0.00%) |
Show
Entries
CS Diagnostics Corp Frequently Asked Questions
What is CS Diagnostics Corp(CSDX)'s stock price today?
The current price of CSDX is $0.07. The 52 week high of CSDX is $0.40 and 52 week low is $0.01.
When is next earnings date of CS Diagnostics Corp(CSDX)?
The next earnings date of CS Diagnostics Corp(CSDX) is 2026-08-14 Est..
Does CS Diagnostics Corp(CSDX) pay dividends? If so, how much?
CS Diagnostics Corp(CSDX) does not pay dividend.
Guru Commentaries on OTCPK:CSDX
No articles.
Press Release
Articles on CS Diagnostics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers